Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception.

Weinfurt KP, Sulmasy DP, Schulman KA, Meropol NJ.

Theor Med Bioeth. 2003;24(4):329-44.

PMID:
14620488
[PubMed - indexed for MEDLINE]
2.

The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.

Sulmasy DP, Astrow AB, He MK, Seils DM, Meropol NJ, Micco E, Weinfurt KP.

Cancer. 2010 Aug 1;116(15):3702-11. doi: 10.1002/cncr.25201.

PMID:
20564120
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Unrealistic optimism and the ethics of phase I cancer research.

Crites J, Kodish E.

J Med Ethics. 2013 Jun;39(6):403-6. doi: 10.1136/medethics-2012-100752. Epub 2012 Oct 31.

PMID:
23118468
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?

Miller FG, Joffe S.

Clin Trials. 2008;5(6):617-23. doi: 10.1177/1740774508097576.

PMID:
19029210
[PubMed - indexed for MEDLINE]
5.

Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.

Horng S, Grady C.

IRB. 2003 Jan-Feb;25(1):11-6. No abstract available.

PMID:
12833900
[PubMed - indexed for MEDLINE]
6.

Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis.

Kimmelman J, Palmour N.

J Med Ethics. 2005 Apr;31(4):209-14.

PMID:
15800361
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Quality of informed consent in cancer clinical trials: a cross-sectional survey.

Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC.

Lancet. 2001 Nov 24;358(9295):1772-7.

PMID:
11734235
[PubMed - indexed for MEDLINE]
8.

Therapeutic misconception in early phase gene transfer trials.

Henderson GE, Easter MM, Zimmer C, King NM, Davis AM, Rothschild BB, Churchill LR, Wilfond BS, Nelson DK.

Soc Sci Med. 2006 Jan;62(1):239-53. Epub 2005 Jul 5.

PMID:
16000230
[PubMed - indexed for MEDLINE]
9.

The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.

Weinfurt KP, Castel LD, Li Y, Sulmasy DP, Balshem AM, Benson AB 3rd, Burnett CB, Gaskin DJ, Marshall JL, Slater EF, Schulman KA, Meropol NJ.

Cancer. 2003 Jul 1;98(1):166-75.

PMID:
12833469
[PubMed - indexed for MEDLINE]
Free Article
10.

Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?

Weinfurt KP, Seils DM, Lin L, Sulmasy DP, Astrow AB, Hurwitz HI, Cohen RB, Meropol NJ.

J Clin Oncol. 2012 Dec 10;30(35):4396-400. doi: 10.1200/JCO.2011.40.6587. Epub 2012 Oct 22.

PMID:
23091107
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Study of cohort-specific consent and patient control in phase I cancer trials.

Daugherty CK, Ratain MJ, Minami H, Banik DM, Vogelzang NJ, Stadler WM, Siegler M.

J Clin Oncol. 1998 Jul;16(7):2305-12.

PMID:
9667244
[PubMed - indexed for MEDLINE]
12.

Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.

Daugherty CK.

J Clin Oncol. 1999 May;17(5):1601-17.

PMID:
10334550
[PubMed - indexed for MEDLINE]
13.

Impact of quality of life on patient expectations regarding phase I clinical trials.

Cheng JD, Hitt J, Koczwara B, Schulman KA, Burnett CB, Gaskin DJ, Rowland JH, Meropol NJ.

J Clin Oncol. 2000 Jan;18(2):421-8. Erratum in: J Clin Oncol 2000 Apr;18(8):1807.

PMID:
10637258
[PubMed - indexed for MEDLINE]
14.

Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.

Pentz RD, White M, Harvey RD, Farmer ZL, Liu Y, Lewis C, Dashevskaya O, Owonikoko T, Khuri FR.

Cancer. 2012 Sep 15;118(18):4571-8. doi: 10.1002/cncr.27397. Epub 2012 Jan 31.

PMID:
22294385
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent.

Weinfurt KP, Seils DM, Tzeng JP, Compton KL, Sulmasy DP, Astrow AB, Solarino NA, Schulman KA, Meropol NJ.

Med Decis Making. 2008 Jul-Aug;28(4):575-81. doi: 10.1177/0272989X08315242. Epub 2008 Mar 31.

PMID:
18378940
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials.

Weinfurt KP, Depuy V, Castel LD, Sulmasy DP, Schulman KA, Meropol NJ.

Cancer. 2005 Jan 1;103(1):140-7.

PMID:
15534885
[PubMed - indexed for MEDLINE]
Free Article
17.

Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients.

Tomamichel M, Sessa C, Herzig S, de Jong J, Pagani O, Willems Y, Cavalli F.

Ann Oncol. 1995 Apr;6(4):363-9.

PMID:
7619751
[PubMed - indexed for MEDLINE]
18.

Potential subjects' responses to an ethics questionnaire in a phase I study of deep brain stimulation in early Parkinson's disease.

Finder SG, Bliton MJ, Gill CE, Davis TL, Konrad PE, Charles PD.

J Clin Ethics. 2012 Fall;23(3):207-16.

PMID:
23256400
[PubMed - indexed for MEDLINE]
19.

Communication and informed consent in phase 1 trials: a review of the literature.

Cox AC, Fallowfield LJ, Jenkins VA.

Support Care Cancer. 2006 Apr;14(4):303-9. Epub 2006 Jan 28. Review.

PMID:
16633840
[PubMed - indexed for MEDLINE]
20.

[The origin of informed consent].

Mallardi V.

Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27. Italian.

PMID:
16602332
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk